Arylsulphatase A pseudo-deficiency in vascular dementia and Alzheimer's disease

NeuroReport

Volumn 8, Issue 11, 1997, Pages 2613-2616

  Philpot, Michael ^a   Lewis, Keir ^b   Pereria, Maria Luiza ^c   Ward, Chandra ^c   Holmes, Clive ^a   Lovestone, Simon ^a   Fensom, Anthony ^c   Seller, Mary ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Arylsulphatase A; Dementia; Polymorphism

Indexed keywords

CEREBROSIDE SULFATASE; ADENINE; GUANINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; ENZYME DEFICIENCY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BRAIN; ENZYMOLOGY; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; MULTIINFARCT DEMENTIA; ONSET AGE; POINT MUTATION; RISK FACTOR;

ADENINE; AGE OF ONSET; AGED; ALZHEIMER DISEASE; BRAIN; CEREBROSIDE-SULFATASE; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GUANINE; HUMANS; MALE; POINT MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0030608775     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199707280-00038     Document Type: Article

References (25)

1. Kolodny EH. Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, 6th edn. New York, NY: McGraw-Hill 1989: 1721-1750.
2. Gieselmann V, Polten A, Kreysing J et al. Proc Natl Acad Sci USA 86, 9436-9440 (1989).
3. Ricketts M, Goldman D, Long JC et al. Am J Med Genet (Neuropsych Gen) 67, 387-392 (1996).
4. Barth ML, Ward C, Harris A et al. J Med Genet 31, 667-671 (1994).
5. Hyde TM, Ziegler JC and Weinberger DR. Arch Neurol 49, 401-406 (1992).
6. Hageman AT, Gabreels FJ, de Jong JG et al. Arch Neurol 52, 408-413 (1995).
7. Penzien JM, Kappler J, Herschkowitz N et al. Am J Hum Genet 52, 557-564 (1993).
8. Alvarez Leal M, Castillo Solis T, Perez Zuno JA et al. Rev Invest Clin 47, 387-392 (1995).
9. Heavey AM, Philpot MP, Fensom AH et al. Acta Psychiatr Scand 82, 55-59 (1990).
10. Kappler J, Potter W, Gieselmann V et al. Dev Neurosci 13, 228-231 (1991).
11. Park DS, Manowitz P, Stein S et al. Alcohol Clin Exp Res 20, 234-239 (1996).
12. Martinelli P, Ippoliti M, Montanari M et al. Acta Neurol Scand 89, 171-174 (1994).
13. Meyer JS, Obara K, Muramatsu K et al. Dementia 6, 312-322 (1995).
14. Pullicino P, Benedict RHB, Capruso DX et al. Arch Neurol 53, 723-728 (1996).
15. Fredman P, Wallin A, Blennow K et al. Acta Neurol Scand 85, 103-106 (1992).
16. Weinberger LM, Schmidley JW, Schafer IA et al. Neurology 44, 152-154 (1994).
17. World Health Organisation. The International Classification of Diseases, 10th edn. (ICD-10). Geneva, World Health Organisation, 1992.
18. Roman GC, Tatemichi TK, Erkinjuntti T et al. Neurology 43, 250-260 (1993).
19. McKhann G, Drachman D, Folstein M et al. Neurology 34, 939-944 (1984).
20. Folstein M, Folstein S and McHugh P. J Psychiatr Res 12, 189-198 (1975).
21. Rosen WG, Terry RD, Fuld PA et al. Ann Neurol 7, 486-488 (1980).
22. Holmes C, Levy R, McLoughlin DM et al. J Neurol Neurosurg Psychiatry 61, 580-583 (1996).
23. American Psychiatric Association. Diagnositc and Statistical Manual of Mental Disorders (4th edn). Washington: APA, 1994.
24. Mirra SS, Heyman A, McKeel D et al. Neurology 41, 479-486 (1991).
25. Prince M, Cullen M and Mann A. Neurology 44, 97-104 (1994).